Research Topics
| A SchuchatSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Group B streptococcal disease: from trials and tribulations to triumph and trepidationA Schuchat
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Clin Infect Dis 33:751-6. 2001..This recent triumph leaves the professional community treading lightly, alert to the need to monitor for unintended consequences that may threaten recent progress...- Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infectionsAnne Schuchat
Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Matern Child Health J 6:107-14. 2002..To determine levels of prenatal screening for several infections, intrapartum recognition of risk factors, and prophylaxis against mother-to-child transmission of group B streptococcus... 
Epidemiology of group B streptococcal disease in the United States: shifting paradigmsA Schuchat
Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Microbiol Rev 11:497-513. 1998....- Group B streptococcusA Schuchat
Respiratory Disease Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Lancet 353:51-6. 1999..Finally, the pathogen itself has continued to evolve: new capsular serotypes described in the past decade are now causing an important proportion of clinical infections... - Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance GroupR A Hajjeh
Centers for Disease Control and Prevention, Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Atlanta, GA 30333, USA
J Infect Dis 179:449-54. 1999..Further studies are needed to better describe persons with AIDS currently developing cryptococcosis in the era of highly active antiretroviral therapy... - The changing epidemiology of meningococcal disease in the United States, 1992-1996N E Rosenstein
Division of Bacterial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Infect Dis 180:1894-901. 1999..Ongoing surveillance is necessary to determine the stability of serogroup and serosubtype distribution... - Group B streptococcal disease in the era of intrapartum antibiotic prophylaxisS J Schrag
Respiratory Diseases Branch, Division of Bacterial and Mycotic Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
N Engl J Med 342:15-20. 2000..To assess the effects of the preventive efforts, we analyzed trends in the incidence of group B streptococcal disease from 1993 to 1998... - Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistanceA E Fiore
Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Clin Infect Dis 30:71-7. 2000..Empirical use of vancomycin, current prevalence of drug-resistant S. pneumoniae, and degree of nonsusceptibility to cefotaxime may have influenced these findings... - Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United StatesA M Fry
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 188:643-52. 2003..HIV/AIDS was not an independent risk factor for TMP-SMZ nonsusceptibility. Vulnerability to certain serotypes among adults with HIV/AIDS may have implications in prevention strategies... - Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patientsR F Breiman
Centers for Disease Control and Prevention, 1600 Clifton Rd, MS C 12, Atlanta, GA 30333, USA
Arch Intern Med 160:2633-8. 2000..We conducted a retrospective case-control study to evaluate effectiveness of pneumococcal vaccine against invasive disease among adults with human immunodeficiency virus (HIV) infection in San Francisco, Calif, and Atlanta, Ga... - Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working GroupJ D Heffelfinger
Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
Arch Intern Med 160:1399-408. 2000..To provide recommendations for the management of community-acquired pneumonia and the surveillance of drug-resistant Streptococcus pneumoniae (DRSP)... - Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistanceJ F Moroney
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Clin Infect Dis 33:797-805. 2001..Factors other than resistance, such as severity of illness at presentation and advance directive status ("do not resuscitate" orders), appear to have a stronger influence on pneumococcal pneumonia outcomes... - Epidemiology of pneumococcal infections in the elderlyJ C Butler
Arctic Investigations Program, National Center for Infectious Diseases, CDC, Anchorage, Alaska 99508, USA
Drugs Aging 15:11-9. 1999.... - Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccineS E Maslanka
Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Infect Immun 66:2453-9. 1998..The bactericidal results show age-dependent differences in the production and retention of antibody in young children immunized with serogroup C polysaccharide; these differences are not evident with the ELISA data... - Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study GroupN E Rosenstein
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Obstet Gynecol 90:901-6. 1997..To evaluate the potential impact of ACOG and Centers for Disease Control and Prevention (CDC) consensus strategies for the prevention of perinatal group B streptococcal disease... - Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish womenD R Feikin
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA
Am J Obstet Gynecol 184:427-33. 2001..CONCLUSION: Group B streptococcal colonization at delivery, but not at < or = 24 weeks' gestation, was associated with preterm delivery... - The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessmentK Gay
Departments of Medicine and of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA
J Infect Dis 182:1417-24. 2000..Dissemination of the mefE determinant accounted for the rapid increase in the rate of macrolide resistance in our S. pneumoniae population... - Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in NepalA M Fry
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Clin Infect Dis 35:395-402. 2002.... - Group B streptococcal disease prevention practices of obstetrician-gynecologistsJ P Watt
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Disease, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Obstet Gynecol 98:7-13. 2001..To describe group B streptococcal (GBS) disease prevention practices of obstetrician-gynecologists... - Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United StatesJ R Lingappa
Centers for Disease Control and Prevention, Mailstop C 09, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
Vaccine 19:4566-75. 2001..We evaluated the relative burdens of invasive meningococcal disease in US and examined the projected impact of various meningococcal conjugate vaccination strategies on rates of meningococcal disease... - Epidemic nephritis in Nova Serrana, BrazilS Balter
Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Lancet 355:1776-80. 2000..From December, 1997, to July, 1998, 253 cases of acute nephritis were identified in Nova Serrana, Brazil. Seven patients required dialysis, and three patients died. We did a case-control study to investigate the cause of the outbreak... 
Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experienceR A Hajjeh
Division of Bacterial Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS C 25, Atlanta, GA 30333, USA
Vaccine 28:7123-9. 2010..This paper reviews the strategy adopted by the Hib Initiative and the lessons learned in the process, which provide a useful model to accelerate uptake of other new vaccines...- Active bacterial core surveillance of the emerging infections program networkA Schuchat
Centers for Disease Control and Prevention, Mailstop C23, 1600 Clifton Rd, Atlanta, GA 30333, USA
Emerg Infect Dis 7:92-9. 2001..More information on ABCs is available at www.cdc.gov/ncidod/dbmd/abcs. ABCs specimens will soon be available to researchers through an archive... - Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine eraK A Robinson
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, MS D 65, 1600 Clifton Rd NE, Atlanta, GA 30333, USA
JAMA 285:1729-35. 2001..Additionally, a recently licensed pneumococcal 7-valent conjugate vaccine has been recommended for use in young children and could dramatically change the epidemiology of pneumococcal disease... - Toxic shock syndrome in the United States: surveillance update, 1979 1996R A Hajjeh
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Emerg Infect Dis 5:807-10. 1999..We reviewed surveillance data for the period 1979 to 1996, when 5,296 cases were reported, and discuss changes in the epidemiologic features of TSS... - Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organizationR L Davis
Center for Health Studies, the Clinical Planning and Improvement Division, and the Department of Obstetrics and Gynecology, Group Health Cooperative of Puget Sound, Seattle, Washington, USA
Am J Obstet Gynecol 184:603-10. 2001..The guidelines were associated with increased maternal intrapartum antibiotic use, particularly among women at highest risk, and with a decrease in laboratory use for infants... - Invasive group B streptococcal disease in Maryland nursing home residentsK J Henning
Epidemiology and Disease Control Program, Maryland Department of Health and Mental Hygiene, Baltimore, MD, USA
J Infect Dis 183:1138-42. 2001..Further evaluation of intra-NH transmission of GBS is warranted...